Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov. (2017)
Attributed to:
MRC North West Hub for Trials Methodology Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13023-017-0597-1
PubMed Identifier: 28253932
Publication URI: http://europepmc.org/abstract/MED/28253932
Type: Journal Article/Review
Volume: 12
Parent Publication: Orphanet journal of rare diseases
Issue: 1
ISSN: 1750-1172